FDA Approves Drug To Treat HIV Infection in Newborns
https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-drug-treat-hiv-infection-newborns
Read original at benzingaStocks · News reference
GSK Commences Tender Offer To Acquire Nuvalent At $124/Share
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Jun 24, 2026, 3:16 PM
- Checked
- Jun 24, 2026, 3:20 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Measles Kills 2 in Pennsylvania: What Do Prediction Markets Say About the Disease?
Two unvaccinated Pennsylvania residents died of measles, the state’s first deaths in 35 years, as traders see 89% odds of 4,000 U.S. cases.
Read original at benzingaDr. Oz Says The MMR Vaccine Is Not 'Lethal' as Trump Administration Faces Questions Over Vaccine Policy
Oz says the MMR vaccine is “not a lethal vaccine” after Trump warned the combined shot could be “quite lethal” amid vaccine policy scrutiny.
Read original at benzingaWall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
During market turbulence, investors turn to dividend-yielding stocks. Benzinga provides analyst ratings for high-yield stocks in health care.
Read original at benzinga8-K filing — Nuvalent, Inc. (NUVL)
Filed: 2026-07-15 AccNo: 0001193125-26-304126 Size: 257 KB Item 2.01: Completion of Acquisition or Disposition of Assets Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Item 3.03: Material Modifications to Rights of Security Holders Item 5.01: Changes in Control of Registrant Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 9.01: Financial Statements and Exhibits
Read original at edgarHalper Sadeh LLC is Investigating Whether LCII, NUVL, DAN, TMHC are Obtaining Fair Deals for their Shareholders
Investor rights law firm Halper Sadeh LLC is investigating four major corporate transactions to determine if shareholders are receiving fair deals. The investigations cover LCI Industries' sale to Patrick Industries, Nuvalent's acquisition by GSK, Dana Incorporated's merger with Eaton Corporation, and Taylor Morrison's sale to Berkshire Hathaway. The firm is examining potential securities law violations and breaches of fiduciary duties, particularly regarding insider benefits and terms that may limit competing offers.
Read original at globenewswire-inc